Download Image
    
Share
  
Post
Metronidazole for COVID-19
1 study with 44 patients
Hospital Icon Control
Hospital Icon Metronidazole Serious Outcome Risk
No significant improvements are seen in meta analysis to date.
COVID-19 Metronidazole studies. Nov 2025. c19early.org
0 0.5 1 1.5+ All studies -20% Hospitalization 25% RCTs -20% Late -20% Favorsmetronidazole Favorscontrol
Sep 30
2021
 Kazempour et al., Iranian Journal of Pharmaceutical Research, doi:10.22037/ijpr.2021.114567.14917 Anti-inflammatory Effect of Metronidazole in Hospitalized Patients with Pneumonia due to COVID-19
20% higher ICU admission (p=1), 25% shorter hospitalization (p=0.9), and 43% higher need for oxygen therapy (p=0.8). RCT 44 hospitalized patients with COVID-19 pneumonia showing no significant differences for oxygen saturation, length of hospital stay, or mortality with metronidazole treatment. The metronidazole group had significantly lower ESR levels ..